Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients

BACKGROUND: Immunocompromised patients have an increased risk of developing severe COVID disease, as well as a tendency to suboptimal responses to vaccines. The objective of this study was to evaluate the specific cellular and humoral adaptive immune responses of a cohort of kidney transplant recipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Flores, Isabel, Juarez, Ignacio, Aiffil Meneses, Arianne S., Lopez-Gomez, Ana, Romero, Natividad Calvo, Rodriguez-Cubillo, Beatriz, Moreno de la Higuera, María Angeles, Peix-Jiménez, Belen, Gonzalez-Garcia, Raquel, Baos-Muñoz, Elvira, Vilela, Ana Arribi, Gómez Del Moral, Manuel, Martínez-Naves, Eduardo, Sanchez-Fructuoso, Ana Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931894/
https://www.ncbi.nlm.nih.gov/pubmed/36817489
http://dx.doi.org/10.3389/fimmu.2023.1111569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931894/
https://www.ncbi.nlm.nih.gov/pubmed/36817489
http://dx.doi.org/10.3389/fimmu.2023.1111569

Ejemplares similares